Predict your next investment

Venture Capital
avalon-ventures.com

See what CB Insights has to offer

Investments

253

Portfolio Exits

58

Funds

12

Partners & Customers

1

About Avalon Ventures

Avalon Ventures is a San Diego-based venture capital fund focusing on seed and early stage companies in life sciences, wireless communications and Web 3.0 digital media, primarily in California and the Northeast.

Avalon Ventures Headquarter Location

1134 Kline Street

La Jolla, California, 92037,

United States

858-348-2180

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Avalon Ventures

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Avalon Ventures in 1 Expert Collection, including Synthetic Biology.

S

Synthetic Biology

382 items

Latest Avalon Ventures News

Joy announces USD 20M in new funding

Sep 6, 2021

Joy's explosive organic growth and modern take on wedding planning enabled the company to raise USD 20 million in new funding, bringing the company's total funding to USD 46.5 million. The round was led by Valor Siren Ventures, and joined by Ashton Kutcher and Guy Oseary's Sound Ventures, Zola Global, Avalon Ventures, and Sierra Ventures.

Avalon Ventures Investments

253 Investments

Avalon Ventures has made 253 investments. Their latest investment was in Nerio Therapeutics as part of their Series A on October 10, 2021.

CBI Logo

Avalon Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/7/2021

Series A

Nerio Therapeutics

$3.5M

No

1

8/18/2021

Series B

Jnana Therapeutics

$50M

No

4

7/21/2021

Series B

Joy

$20M

No

5

4/20/2021

Series B

Subscribe to see more

$99M

Subscribe to see more

10

3/29/2021

Series A - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/7/2021

8/18/2021

7/21/2021

4/20/2021

3/29/2021

Round

Series A

Series B

Series B

Series B

Series A - II

Company

Nerio Therapeutics

Jnana Therapeutics

Joy

Subscribe to see more

Subscribe to see more

Amount

$3.5M

$50M

$20M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

1

4

5

10

10

Avalon Ventures Portfolio Exits

58 Portfolio Exits

Avalon Ventures has 58 portfolio exits. Their latest portfolio exit was Kaltura on July 21, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/21/2021

IPO

$991

8

6/11/2021

IPO

$991

1

2/26/2021

Acquired

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

10

Date

7/21/2021

6/11/2021

2/26/2021

00/00/0000

00/00/0000

Exit

IPO

IPO

Acquired

Subscribe to see more

Subscribe to see more

Companies

Subscribe to see more

Subscribe to see more

Valuation

$991

$991

Acquirer

Subscribe to see more

Subscribe to see more

Sources

8

1

10

10

10

Avalon Ventures Fund History

12 Fund Histories

Avalon Ventures has 12 funds, including Avalon Ventures XI.

Closing Date

Fund

Fund Type

Status

Amount

Sources

9/6/2016

Avalon Ventures XI

Early-Stage Venture Capital

$116.53M

3

8/30/2012

Avalon Ventures X

Early-Stage Venture Capital

$201.63M

1

8/1/2012

10Th Capital Fund

$201.6M

7/19/2010

Avalon Ventures IX

Subscribe to see more

$99M

10

2/27/2008

Avalon Ventures VIII

Subscribe to see more

$99M

10

Closing Date

9/6/2016

8/30/2012

8/1/2012

7/19/2010

2/27/2008

Fund

Avalon Ventures XI

Avalon Ventures X

10Th Capital Fund

Avalon Ventures IX

Avalon Ventures VIII

Fund Type

Early-Stage Venture Capital

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Status

Amount

$116.53M

$201.63M

$201.6M

$99M

$99M

Sources

3

1

10

10

Avalon Ventures Partners & Customers

1 Partners and customers

Avalon Ventures has 1 strategic partners and customers. Avalon Ventures recently partnered with GlaxoSmithKline on April 4, 2013.

Date

Type

Business Partner

Country

News Snippet

Sources

4/23/2013

Partner

GlaxoSmithKline

United Kingdom

Avalon Ventures GlaxoSmithKline Launch Sitari Pharm With 10 Million Series A And RD Support

Community of Innovation , founded in 2013 , provides operational support to Sitari Pharmaceuticals , the first company funded through the Avalon-GlaxoSmithKline collaboration , as well as existing Avalon Ventures portfolio companies , Afraxis , Avelas Biosciences , RQx Pharmaceuticals and Sova Pharmaceuticals .

4

Date

4/23/2013

Type

Partner

Business Partner

GlaxoSmithKline

Country

United Kingdom

News Snippet

Avalon Ventures GlaxoSmithKline Launch Sitari Pharm With 10 Million Series A And RD Support

Community of Innovation , founded in 2013 , provides operational support to Sitari Pharmaceuticals , the first company funded through the Avalon-GlaxoSmithKline collaboration , as well as existing Avalon Ventures portfolio companies , Afraxis , Avelas Biosciences , RQx Pharmaceuticals and Sova Pharmaceuticals .

Sources

4

Avalon Ventures Team

8 Team Members

Avalon Ventures has 8 team members, including current Chief Financial Officer, Douglas Downs.

Name

Work History

Title

Status

Douglas Downs

Chief Financial Officer

Current

Tighe M Reardon

Chief Financial Officer

Current

Kevin Kinsella

Managing Partner

Current

Brady Bohrmann

Managing Director

Current

Jay B Lichter

Managing Director

Current

Name

Douglas Downs

Tighe M Reardon

Kevin Kinsella

Brady Bohrmann

Jay B Lichter

Work History

Title

Chief Financial Officer

Chief Financial Officer

Managing Partner

Managing Director

Managing Director

Status

Current

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.